Clinical Trials Browser

Phase 2 × Pituitary Neoplasms × Ipilimumab × Clear all

NCT04042753 2025-08-08

Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors

Phase 2 Active not recruiting

Pituitary Diseases, Pituitary Neoplasms